|Bid||3,175.00 x 0|
|Ask||3,202.50 x 0|
|Day's Range||3,125.50 - 3,211.00|
|52 Week Range||2,080.00 - 3,999.00|
|Beta (5Y Monthly)||0.47|
|PE Ratio (TTM)||8,969.65|
|Forward Dividend & Yield||49.88 (1.44%)|
|Ex-Dividend Date||Jun 14, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for MRK.BALearn more
Moderna CEO Stéphane Bancel said that based on his conversations with scientists, current vaccines will likely be less effective against the Omicron variant. Yahoo Finance's Ines Ferre provides details.
Columbia University professor Meg Fitzgerald speaks with Yahoo Finance Live about the uncertainty surrounding Omicron, the effectiveness (or lack thereof) of travel bans, the demand for booster shots, global vaccination rates, and the strained U.S. health care system.
Should Americans wait to get a potential Omicron-fighting vaccine booster? One epidemiologist says, "Absolutely not."